ScreenerHero
FMEFresenius Medical Care AG & Co. KGaA
XETRA · DE · Healthcare · Medical Care Facilities · freseniusmedicalcare.com
40.37EUR-1.28%Mkt Cap: 11.94B $P/E: 12.32

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and di…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$90.30BUSDP/E 13.7
FRE
Fresenius SE & Co. KGaA Inhaber-Aktien o.N.
$28.29BUSDP/E 16.7
THC
Tenet Healthcare Corporation
$21.62BUSDP/E 10.4
EHC
Encompass Health Corporation
$12.01BUSDP/E 20.3
DVA
DaVita Inc.
$11.38BUSDP/E 15.0
ENSG
The Ensign Group, Inc.
$10.64BUSDP/E 28.6
UHS
Universal Health Services, Inc. Class B
$10.16BUSDP/E 7.0
PACS
PACS Group Inc.
$7.01BUSDP/E 25.9
CHE
Chemed Corporation
$7.00BUSDP/E 26.9
LFST
LifeStance Health Group Inc. Common Stock
$4.90BUSDP/E 98.7
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.43BUSDP/E 22.4
MCOV-B
Medicover AB (publ)
$3.49BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.67BUSDP/E 26.3
OPCH
Option Care Health, Inc.
$3.50BUSDP/E 17.7
BKD
Brookdale Senior Living Inc.
$2.89BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.4
EMEIS
Emeis SA
$2.46BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.55BUSD
GRDN
Guardian Pharmacy Services Inc. Class A Common Stock
$2.41BUSDP/E 36.5
ADUS
Addus HomeCare Corporation
$2.24BUSDP/E 21.0

Key Statistics

Company
Market Cap11.94B $
Enterprise Value23.67B $
Revenue (TTM)21.12B $
Gross Profit5.47B $
Net Income (TTM)1.06B $
Revenue/Share75.31 USD
Last Price40.37 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees107.2K
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)12.32
P/E (Forward)9.30
PEG0.83
EV/EBITDA8.00
EV/Revenue1.12
P/S0.55
P/B0.85
EPS (TTM)3.32
EPS (Forward)4.34
52W Range
34.6043% of range47.86
52W High47.86 EUR
52W Low34.60 EUR
Profitability
Gross Margin25.62%
Oper. Margin10.77%
EBITDA Margin14.01%
Profit Margin4.98%
ROE7.35%
ROA3.16%
Growth
Revenue Growth1.40%
Earnings Growth5.50%
Cash Flow & Leverage
Operating CF2.91B $
CapEx (TTM)994.97M $
FCF Margin10.41%
FCF Yield18.42%
Net Debt10.78B $
Net Debt/EBITDA3.64
Balance Sheet
Debt/Equity0.81
Current Ratio1.07
Quick Ratio0.63
Book Value/Sh47.19 EUR
Cash/Share3.988 EUR
Dividends
Fwd Div Rate1.490 EUR
Trail. Div Rate1.490 EUR
Div. Yield3.64%
5Y Avg Yield3.13%
Payout Ratio44.88%
Ex-Div DateMay 22, 2026
Pay Date—
Splits
Last Split3:1
Split DateJun 18, 2007
Analyst Consensus
Rating3.1 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)42.80 EUR
Upside (mean)+6.0%
Target Range30.00 EUR – 67.00 EUR
€30.00+6.0% to mean€67.00
# Analysts17
Ownership
Shares Out.268.56M
Float181.89M
Insiders28.60%
Institutions49.29%
Technical
SMA 5041.80 (-3.4%)
SMA 20039.77 (+1.5%)
Beta0.84
S&P 52W Chg18.16%
Avg Vol (30d)732.73K
Avg Vol (10d)616.99K
Technical Indicators
RSI (14)42.3
MACD-0.3109
MACD Signal-0.0213
MACD Hist.-0.2896
BB Upper45.09 EUR
BB Middle42.36 EUR
BB Lower39.63 EUR
BB Width12.90%
ATR (14)0.9603 EUR
Vol Ratio (20d)0.64x